National Institutes of Health grant notices posted in 2024, now closed
609 National Institutes of Health grant notices posted on Grants.gov in 2024 that have closed, with their numbers and dates.
- PA-25-249: NIAID, NIDDK, NIDA, and NIAAA Research Opportunities for New and "At-Risk" Investigators (R01 Clinical Trial Optional)
- RFA-CA-25-005: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (R01 Clinical Trial Optional)
- RFA-CA-25-007: Revision Applications for Incorporation of Novel NCI-Supported Technology to Accelerate Cancer Research (P50 Clinical Trial Optional)
- RFA-CA-25-006: Revision Applications for Incorporation of Novel NCI- Supported Technology to Accelerate Cancer Research (U01 Clinical Trial Optional)
- PAR-25-332: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R01 Clinical Trial Optional)
- PAR-25-331: Research on Current Topics in Alzheimer's Disease and Its Related Dementias (R21 Clinical Trial Optional)
- PAR-25-056: Secondary Analysis of Existing Datasets in Heart, Lung, and Blood Diseases and Sleep Disorders (R21 Clinical Trial Not Allowed)
- RFA-DA-25-074: Ex Vivo Models for Studies at the Intersection of HIV and Addictive Substance Use (R01 Clinical Trial Not Allowed)
- RFA-EY-25-002: Advancing Vision Health Equity through Multi-level Interventions and Community-Engaged Research (R01 - Clinical Trial Optional)
- PAR-25-099: Planning for Product Development Strategy (R34 Clinical Trial Not Allowed)
- RFA-DK-26-006: NIDDK Catalyst Award (DP1 Clinical Trial Not Allowed)
- PA-25-307: NIH Exploratory/Developmental Research Project Grant (Parent R21 Basic Experimental Studies with Humans Required)
- PA-25-303: NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)
- PAR-25-326: Ultra-Rare Gene-based Therapy (URGenT) Network Resource Access (X01, Clinical Trial Not Allowed)
- PAR-25-315: Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R01 Clinical Trial Not Allowed)
- PAR-25-316: Elucidating Immunometabolic Responses to HIV Infection that Increase TB or HBV Risk (R21 Clinical Trial Not Allowed)
- RFA-DA-25-077: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R33 Clinical Trial Optional)
- RFA-DA-25-078: HEAL Initiative: Translating Research to Practice to End the Overdose Crisis (R61/R33 Clinical Trial Optional)
- RFA-DC-25-004: NIDCD Research Opportunities for New Investigators to Promote Workforce Development (R01 Clinical Trial Optional)
- PAS-25-236: D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
- RFA-CA-25-001: Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- RFA-CA-25-003: Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
- RFA-CA-25-004: Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- RFA-CA-25-002: Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
- RFA-HL-25-011: Limited Competition: Small Grant Program for NHLBI K01/K08/K23/K25 Recipients (R03 Clinical Trial Optional)
- RFA-DK-25-023: Continuation of the NIDDK Hematology Central Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-CA-25-019: Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
- PAR-25-247: Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
- RFA-AA-24-012: Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
- PAR-25-277: High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
- PAR-25-154: HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
- PAR-25-155: Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- PAR-25-028: Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
- RFA-NR-25-003: Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
- RFA-AI-24-080: Broad Spectrum Products Against Multiple Neurotoxin Botulinum Serotypes (R61/R33 Clinical Trial Not Allowed)
- PAR-25-029: Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
- PAR-25-045: NIDCR Small Research Grants for Oral Health Data Analysis and Statistical Methodology Development (R03 Clinical Trial Not Allowed)
- PAR-25-157: Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
- PAR-25-308: Small Business Informatics Tools for the Pangenome (R43 Clinical Trial Not Allowed)
- PAR-25-309: Small Business Informatics Tools for the Pangenome (R41 Clinical Trial Not Allowed)
- RFA-RM-24-010: Complement-ARIE New Approach Methodologies (NAMs) Technology Development Centers (UM1 Clinical Trial Optional)
- PAR-25-156: Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
- PAR-25-224: Integrative Research to Understand the Impact of Sex Differences on the Molecular Determinants of AD Risk and Responsiveness to Treatment (U01 Clinical Trial Optional)
- RFA-AG-25-001: Deriving Common Data Elements from Real-World Data for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U24 Clinical Trial Not Allowed)
- PAR-24-279: Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- PAR-24-280: Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- PAR-25-330: Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
- PAR-25-230: Ancillary Studies to Ongoing Clinical Projects (R21 Clinical Trial Not Allowed)
- PAR-24-287: Limited Competition: Small Grant Program for NIAMS K01, K08, K23, and K25 Recipients (R03) (Clinical Trials Not Allowed)
- PAR-24-289: Ancillary Studies to Ongoing Clinical Projects (R01 Clinical Trial Not Allowed)
- RFA-AG-25-015: Coordination Center for the Alzheimers Disease Sequencing Project Consortium (U01 Clinical Trial Not Allowed)
- RFA-DK-26-001: NIDDK Centers for Diabetes Translation Research (P30 Clinical Trial Optional)
- RFA-MD-24-011: Limited Competition: Research Centers in Minority Institutions (RCMI) Coordinating Center (U24 - Clinical Trial Optional)
- RFA-EY-25-001: BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
- PAR-24-319: NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Required)
- PAR-24-286: NIMH Career Transition Award for Tenure-Track Intramural Investigators (K22 Independent Clinical Trial Not Allowed)
- RFA-HG-25-007: Informatics Tools for the Pangenome (U01 Clinical Trial Not Allowed)
- RFA-OD-25-001: High-Priority Research in Tobacco Regulatory Science (R01 Clinical Trial Optional)
- RFA-HD-26-005: Rehabilitation Research Career Development Programs (K12 Clinical Trial Optional)
- PAR-25-239: NIDCR Prospective Observational or Biomarker Validation Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- PAR-25-242: Mobile Health: Technology and Outcomes in Low and Middle Income Countries (R21/R33 - Clinical Trial Optional)
- RFA-AG-24-049: Artificial Intelligence in Pre-clinical Drug Development for AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-ES-25-003: Time-Sensitive Research Opportunities in Environmental Health Sciences (R21 Clinical Trials Not Allowed)
- PAR-24-317: NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Independent Clinical Trial Not Allowed)
- PAR-24-318: NCI Continuing Umbrella of Research Experiences (CURE) Non-Mentored Research Scientist Career Development Award (K22 Clinical Trial Required)
- PAR-24-320: NCI Continuing Umbrella of Research Experiences (CURE) Mentored Clinical Scientist Research Career Development Award (K08 Clinical Trial Not Allowed)
- RFA-RM-24-012: In Vivo Non-Invasive Optical Imaging Approaches for Biological Systems (UG3/UH3 Clinical Trials Not Allowed
- PAR-25-300: Targeting Cell Surface HIV Envelope for Cell Elimination (R01 Clinical Trial Not Allowed)
- RFA-DA-26-003: Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R01 Clinical Trials Required)
- RFA-DA-26-004: Research to Address Systemic and Structural Barriers and Facilitators to Improve the HIV Pre-Exposure Prophylaxis (PrEP) Care Continuum for People Who Use Substances (R34 Clinical Trials Required)
- PAR-25-192: Alcohol Health Services Research (R34 Clinical Trial Optional)
- PA-25-245: Alcohol Health Services Research (R01 Clinical Trial Optional)
- PA-25-163: Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- PAR-25-193: Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- PAR-25-238: NLM Research Grants in Biomedical Informatics and Data Science (R01 Clinical Trial Optional)
- PAR-25-214: Development of Animal Models and Related Biological Materials for Down Syndrome Research (R21 Clinical Trial Not Allowed)
- PAS-25-161: HIV Prevention and Alcohol (R34 Clinical Trials Optional)
- PAS-25-208: HIV Prevention and Alcohol (R01 Clinical Trials Optional)
- PAR-25-171: Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research (R01 Clinical Trial Optional)
- RFA-AI-24-076: Advancing Translation of Long-Acting Strategies for HIV and HIV-Associated Co-infections (AT LASt) (R61/R33 Clinical Trial Not Allowed)
- PAR-25-082: Co-infection and Cancer (R01 Clinical Trial Not Allowed)
- PAR-25-186: Cancer Epidemiology Cohorts: Building the Next Generation of Research Cohorts (U01 Clinical Trial Not Allowed)
- PAR-25-083: Co-infection and Cancer (R21 Clinical Trial Not Allowed)
- PAS-25-190: Research Opportunities for New and "At-Risk" Investigators to Promote Workforce Diversity (R01 Clinical Trial Optional)
- PAR-25-106: Innovative Research in Cancer Nanotechnology (IRCN; R01 Clinical Trial Not Allowed)
- PAR-25-107: Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R01 Clinical Trial Not Allowed)
- PAR-25-034: Novel Assays to Address Translational Gaps in Treatment Development (UG3/UH3 Clinical Trial Optional)
- PAR-25-035: Building in vivo Preclinical Assays of Circuit Engagement for Application in Therapeutic Development (R01 Clinical Trial Not Allowed)
- RFA-MH-26-110: Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R01 Clinical Trial Not Allowed)
- RFA-MH-26-111: Role of T-Cells in HIV CNS Reservoir Seeding, Persistence, and Neuropathogenesis (R21 Clinical Trial Not Allowed)
- PAR-25-261: NIDA Avant-Garde Program for HIV and Substance Use Disorder Research (DP1 Clinical Trial Optional)
- RFA-DA-26-016: Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R43 - Clinical Trials Optional)
- RFA-DA-26-017: Medical Devices for Pediatric Population Affected by Substance Use and Addiction (R41 - Clinical Trials Optional)
- RFA-NR-25-002: NINR Resources and Related Research Projects in Firearm Injury Prevention (R24 Clinical Trial Not Allowed)
- RFA-NS-25-027: Limited Competition: NIH Neuroscience Doctoral Readiness Program (DR. Program) (R25 Clinical Trial Not Allowed)
- PAR-24-290: NEI Postbaccalaureate Opportunities in Vision Science (POVS) Research Education Program (R25 Clinical Trial Not Allowed)
- PAR-25-254: Understanding Expectancies in Cancer Symptom Management (R01 Clinical Trial Required)
- RFA-RM-24-008: Limited Competition: Competing Revisions to Support Clinical Trials in Somatic Cell Genome Editing (U19 Clinical Trial Required)
- PA-25-294: Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R01 Clinical Trial Optional)
- PA-25-295: Innovative Approaches to Studying Cancer Communication in the New Information Ecosystem (R21 Clinical Trial Optional)
- PAR-25-278: Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
- RFA-NS-25-016: BRAIN Initiative: Promoting Health for All Through BRAIN Technology Partnerships (R34 - Clinical Trials Not Allowed)
- PAR-25-220: Leveraging Extant Data to Understand Developmental Trajectories of Late Talking Children (R21 Clinical Trial Not Allowed)
- PAR-25-217: Information and Practice Needs Relevant to Late Talking Children (R21 Clinical Trial Not Allowed)
- PAR-25-275: Research Opportunities in Established Cancer Epidemiology Cohort Studies (U01 Clinical Trial Not Allowed)
- RFA-HG-25-002: Advancing Genomic Medicine Research (R01 Clinical Trial Optional)
- RFA-HG-25-003: Advancing Genomic Medicine Research (R21 Clinical Trial Optional)
- RFA-HG-25-004: Advancing Genomic Medicine Research (R03 Clinical Trial Not Allowed)
- PAR-25-128: Biology of Bladder Cancer (R21 Clinical Trial Optional)
- PAR-25-129: Biology of Bladder Cancer (R01 Clinical Trial Optional)
- PAR-25-095: Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
- PA-25-126: NICHD Small Research Grant Program (R03 Basic Experimental Studies with Humans Required)
- PAR-25-072: Pragmatic Trials across the Cancer Control Continuum (UG3/UH3 Clinical Trial Required)
- PAR-25-204: NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)
- PAR-24-316: NCI Mentored Research Scientist Development Award to Promote Diversity (K01 Independent Clinical Trial Not Allowed)
- RFA-HG-25-005: Enhancing Reuse of NHGRI Data Assets (R03 Clinical Trial Not Allowed)
- PA-25-246: Small Research Grant Program for the Next Generation of Researchers in AD/ADRD Research (R03 Clinical Trial Optional)
- PAR-25-094: Impacts of climate change across the cancer control continuum (R01 Clinical Trial Optional)
- PAR-25-152: Impacts of climate change across the cancer control continuum (R21 Clinical Trial Optional)
- PAR-25-084: Advancing Research Careers (ARC) Predoctoral to Postdoctoral Transition Award to Promote Diversity (F99/K00 - Clinical Trial Not Allowed)
- PAR-25-109: Small Research Grants for Analyses of Gabriella Miller Kids First Pediatric Research Data (R03 Clinical Trial Not Allowed)
- PAR-25-092: Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
- PAR-25-037: Cellular and Molecular Biology of Complex Brain Disorders (R21 Clinical Trial Not Allowed)
- PAR-25-039: Schizophrenia and related disorders during mid- to late-life (R01 Clinical Trial Optional)
- PAR-25-038: Cellular and Molecular Biology of Complex Brain Disorders (R01 Clinical Trial Not Allowed)
- PAR-25-040: Schizophrenia and related disorders during mid- to late-life (R21 Clinical Trial Optional)
- PAR-25-110: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R01 Clinical Trial Optional)
- PAR-25-111: Translational Research in Maternal and Pediatric Pharmacology and Therapeutics (R21 Clinical Trial Optional)
- PAR-25-176: Limited Competition: Small Grant Program for ORIP Special Emphasis Research Career Award (SERCA) K01 Recipients (R03 Clinical Trial Not Allowed)
- PA-25-173: Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R21 Clinical Trial Not Allowed)
- PA-25-174: Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE) (R01 Clinical Trial Not Allowed)
- PAR-25-228: Investigator Initiated Innovation in Computational Genomics and Data Science (R01 Clinical Trial Not Allowed)
- PAR-25-229: Investigator Initiated Innovation in Computational Genomics and Data Science (R21 Clinical Trial Not Allowed)
- RFA-HD-26-004: Contraceptive Development Research Centers (P50 Clinical Trial Optional)
- PAR-25-067: Social disconnection and Suicide Risk in Late Life (R01 Clinical Trial Optional)
- PAR-25-066: Social disconnection and Suicide Risk in Late Life (R21 Clinical Trial Optional)
- PAR-25-065: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R01 Clinical Trial Optional)
- PAR-25-064: Novel Mechanism Research on Neuropsychiatric Symptoms (NPS) in Alzheimer's Dementia (R21 Clinical Trial Optional)
- PAR-24-130: Aging Research Dissertation Awards to Promote Diversity (R36 Clinical Trial Not Allowed)
- PAR-25-166: NIDCR Small Research Grants for Analyses of Existing Genomics Data (R03 Clinical Trial Not Allowed)
- PAR-25-164: NIDCR Research Grants for Analyses of Existing Genomics Data (R01) (Clinical Trial Not Allowed)
- RFA-HL-26-014: NHLBI SBIR Phase IIB Bridge Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
- RFA-HL-26-015: NHLBI SBIR Phase IIB Small Market Awards to Accelerate the Commercialization of Technologies for Heart, Lung, Blood, and Sleep Disorders and Diseases (R44 Clinical Trial Optional)
- PAR-25-255: Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
- PAR-25-165: Early Stage Investigator HIV/AIDS Research Using Nonhuman Primate (NHP) Models (R21 Clinical Trial Not Allowed)
- PAR-25-202: Technology Development Research for Establishing Feasibility and Proof of Concept (R21 - Clinical Trial Not Allowed)
- RFA-ES-25-001: Epitranscriptomics Crosstalks and Toxicants (EPCOT) (R01 Clinical Trials Not Allowed)
- PAR-25-209: Analytical and Clinical Validation of Biomarkers for Alzheimers Disease (AD) and AD-Related Dementias (ADRD) (U01 Clinical Trial Optional)
- RFA-MD-25-001: NIMHD Minority Health and Health Disparities Research Training (MHRT) Program (T37 Clinical Trial Not Allowed)
- PAR-25-170: Digital Health Technology Derived Biomarkers and Outcome Assessments for Remote Monitoring and Endpoint Development (UG3/UH3 - Clinical Trial Optional)
- PAR-25-240: Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R01 Clinical Trial Optional)
- PAR-25-241: Tobacco, Alcohol, and Cannabis Policy Research for Health Equity (R21 Clinical Trial Optional)
- RFA-NS-25-025: Exploratory/Developmental Research on Guillain Barre Syndrome (GBS) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) (R21 - Clinical Trial Not Allowed)
- PAR-25-054: NINDS Exploratory Clinical Trials (UG3/UH3 Clinical Trial Required)
- PAR-25-237: Improving Care and Outcomes for Cancer Survivors from Sexual and Gender Minority (SGM) Populations (R01 Clinical Trial Optional)
- PAR-25-201: Integrating Mental Health Care into Health Care Systems and Non-Health Settings in Low- and Middle-Income Countries (R01 Clinical Trial Optional)
- PAR-25-108: Microbial-based Cancer Imaging and Therapy - Bugs as Drugs (R21 Clinical Trial Not Allowed)
- PAR-25-133: NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
- PAR-25-218: Research Infrastructure Development for Interdisciplinary Aging Studies (R61/R33 - Clinical Trial Optional)
- PAR-25-219: Advanced-Stage Development and Utilization of Research Infrastructure for Interdisciplinary Aging Studies (R33 Clinical Trial Optional)
- PAR-25-234: NINDS Ruth L. Kirschstein National Research Service Award (NRSA) for Training of Postdoctoral Fellows (F32 Clinical Trial Not Allowed)
- PAR-25-049: NIH SIREN Neurologic Clinical Trials (UG3/UH3 - Clinical Trial Required)
- RFA-DA-26-024: Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional)
- PAR-25-222: NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required)
- PAR-24-306: Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed)
- PAR-25-036: Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
- PAR-25-146: Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed)
- PAR-25-140: In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed)
- PAR-25-117: Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional)
- PAR-25-153: Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed)
- PAR-25-199: Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed)
- PAR-25-198: Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed)
- PAR-25-063: Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed)
- RFA-NS-25-021: BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
- RFA-NS-25-022: BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
- RFA-OD-25-002: Limited Competition: Continued Development of INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed)
- PAR-25-139: NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional)
- RFA-AI-24-074: Combating Antibiotic-Resistant Bacteria Interdisciplinary Research Units (CARBIRUs) (P01 Clinical Trial Not Allowed)
- RFA-DA-26-018: Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional)
- RFA-DA-26-019: Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional)
- PAR-25-077: CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
- RFA-NS-25-019: NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed)
- PAR-24-313: Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
- PAR-25-118: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (UH2 Clinical Trial Not Allowed)
- RFA-MH-25-205: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional)
- RFA-MH-25-206: Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional)
- PAR-25-119: Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed)
- PAR-24-264: High-End Instrumentation (HEI) Grant Program (S10 Clinical Trial Not Allowed)
- PAR-24-265: Shared Instrumentation Grant (SIG) Program (S10 Clinical Trial Not Allowed)
- PAR-24-326: Limited Competition: Basic Instrumentation Grant (BIG) Program (S10 Clinical Trial Not Allowed)
- RFA-DA-25-069: Targeting Inflammasomes in HIV and Substance Use (R01 Clinical Trial Not Allowed)
- RFA-DA-25-068: Targeting Inflammasomes in HIV and Substance Use (R21 Clinical Trial Not Allowed)
- PAR-24-312: Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
- PA-25-212: Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial NOT Allowed)
- RFA-AG-25-027: Facilitating T1 Translational Aging Research: Preclinical and Early Phase Human Studies (UG3/UH3 Clinical Trial Optional)
- PAR-25-076: Development of Resources and Technologies for Enhancing Rigor, Reproducibility, and Translatability of Animal Models in Biomedical Research (R01 Clinical Trial Not Allowed)
- PAR-25-130: The Metastasis Research Network (MetNet): MetNet Research Projects (U01 Clinical Trial Not Allowed)
- PAR-25-223: Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R61/R33 Clinical Trial Required)
- PAR-25-213: Implementation Research for Multi-morbidity Management in the Context of Non-communicable Diseases in Low- and Middle-Income Countries and US Tribal Populations (R01 Clinical Trial Optional)
- PAR-25-114: CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Translational Exploratory/Developmental Research Projects (R21 Clinical Trial Not Allowed)
- RFA-RM-24-011: Pilot projects to enhance utility and usage of data sets from the Molecular Transducers of Physical Activity Consortium (MoTrPAC) (R03 Clinical Trials Not allowed)
- RFA-AI-24-069: Centers for Accelerating Phage (Bacteriophage) Therapy to Combat ESKAPE Pathogens (CAPT-CEP) (P01 Clinical Trial Not Allowed)
- RFA-RM-24-009: Human Virome Program: Developing novel and innovative tools to interrogate and annotate the human virome (U01 Clinical Trial Not Allowed)
- PAR-25-058: Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
- RFA-MD-24-010: Environmental Health Disparities Centers (P50) Clinical Trial Optional
- PAR-25-078: NCI Small Grants Program for Cancer Research (NCI Omnibus) (R03 Clinical Trial Optional)
- RFA-DE-25-003: TMD Collaborative for IMproving PAtient-Centered Translational Research (TMD IMPACT) (U54 Clinical Trial Optional)
- PAR-25-116: Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R01 - Clinical Trial Optional)
- PAR-25-115: Towards a Better Understanding of the Neurological Effects of Infection-Associated Chronic Illnesses (R21 - Clinical Trial Optional)
- RFA-AI-24-068: New Therapeutic Strategies for Genital Herpes (R21/R33 Clinical Trial Not Allowed)
- RFA-DA-25-070: Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R34 Clinical Trial Optional)
- PAR-25-075: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 Clinical Trials Not Allowed)
- PAR-25-074: Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 Clinical Trial Not Allowed)
- RFA-DA-25-072: Ending the Epidemic: New Models of Integrated HIV/AIDS, Addiction, and Primary Care Services (R01 Clinical Trial required)
- RFA-EB-25-002: Building Biomedical Engineering Education, Research, and Innovation at Historically Black Colleges and Universities (HBCU eBETA) (UG3/UH3 Clinical Trial Not Allowed)
- PAR-24-276: Data Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative U24 Clinical Trial Required)
- RFA-NS-24-038: Human Brain Single-cell Genomics Explorer (U24 - Clinical Trial Not Allowed)
- PAR-24-304: Revision Applications for Validation of Biomarker Assays Developed Through NIH-Supported Research Grants (R01 Clinical Trial Not Allowed)
- RFA-CA-24-033: NCI National Clinical Trials Network - Network Lead Academic Participating Sites (UG1 Clinical Trial Not Allowed)
- PA-25-121: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
- PA-25-123: Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
- RFA-CA-24-031: Limited Competition: NCI National Clinical Trials Network - Network Group Statistics and Data Management Centers (U10 Clinical Trial Required)
- RFA-CA-24-030: Limited Competition: NCI National Clinical Trials Network - Network Group Operations Centers (U10 Clinical Trial Required)
- RFA-CA-24-032: Single Source: NCI National Clinical Trials Network - Canadian Collaborating Clinical Trials Network (U10 Clinical Trial Required)
- RFA-CA-24-034: Single Source: NCI National Clinical Trials Network - Network Radiotherapy and Imaging Core Services Center (U24 Clinical Trial Not Allowed)
- RFA-CA-24-035: NCI National Clinical Trials Network - Network Group Integrated Translational Science Centers (UG1 Clinical Trial Not Allowed)
- RFA-NS-25-020: HEAL Initiative: Understanding Individual Differences in Human Pain Conditions (R01 - Clinical Trial Optional)
- RFA-AI-24-067: Development of Alternative Human Models of Radiation-Induced Injuries (Extracorporeal Systems) (U01 Clinical Trial Not Allowed)
- PAR-24-305: Centers for Precision Disease Modeling (U54) (Clinical Trials Not Allowed)
- RFA-AG-25-008: Centers on the Demography and Economics of Aging and Alzheimers Disease and Alzheimers Disease-Related Dementias Coordinating Center (U24 Clinical Trial Optional)
- RFA-AG-25-007: Centers on the Demography and Economics of Aging, Including Alzheimer's Disease and Alzheimer's Disease-Related Dementias (AD/ADRD) (D and E Centers) (P30 Clinical Trial Optional)
- RFA-CA-25-010: Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT) - Tobacco Use Treatment for Cancer Survivors (UG3/UH3 Clinical Trial Required)
- PAR-25-055: Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
- PAR-25-050: Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
- PAR-24-294: Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
- RFA-CA-25-013: Discovery and Development of Natural Products for Cancer Interception and Prevention (UG3/UH3 Clinical Trial Not Allowed)
- RFA-CA-25-009: Scaling-up and Maintaining Evidence-based Interventions to Maximize Impact on Cancer (SUMMIT)- Lung Cancer Screening (UG3/UH3 Clinical Trial Required)
- PAR-25-061: Biomedical Research Facilities (C06 Clinical Trial Not Allowed)
- RFA-DA-26-009: Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R01 Clinical Trials Not Allowed)
- RFA-DA-26-010: Mitochondrial-associated Mechanisms of Neuropathological and Immunodeficient Aging in the Context of HIV and SUD (R21 Clinical Trials Not Allowed)
- RFA-CA-24-036: Cancer Immunoprevention Network (CIP-Net) Resource Coordinating Center (U24 Clinical Trials Not Allowed)
- RFA-DK-25-022: Precision Medicine for Type 1 Diabetic Nephropathy (U01 Clinical Trial Not Allowed)
- RFA-NS-25-024: Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
- PAR-25-051: Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development of Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
- RFA-NS-25-017: BRAIN Initiative: Optimization of Instrumentation and Device Technologies for Recording and Modulation in the Nervous System (U01 Clinical Trials Not Allowed)
- RFA-NS-25-018: BRAIN Initiative: New Technologies and Novel Approaches for Recording and Modulation in the Nervous System (R01 Clinical Trial Not Allowed)
- RFA-NR-25-001: Advancing Health Equity through Interventions to Prevent and Address Housing Instability (R01 Clinical Trial Optional)
- PAR-24-299: Behavioral and Integrative Treatment Development Program (R01 Clinical Trial Optional)
- RFA-AI-24-065: Discovery and Development of Novel Therapeutics for Select Fungal Pathogens (R21/R33 Clinical Trial Not Allowed)
- RFA-MH-25-200: Early Psychosis Intervention Network (EPINET): Learning Health Care Research to Improve Mental Health Services and Outcomes (P01 Clinical Trial Optional)
- PAR-24-298: Mechanism for Time-Sensitive Substance Use Research (R21 Clinical Trial Optional)
- PAR-24-297: Imaging - Science Track Award for Research Transition (I/START) (R03 Clinical Trial Optional)
- RFA-AI-24-023: U.S.-South Africa Program for Collaborative Biomedical Research Phase 3 (HIV/AIDS) (R01 Clinical Trial Optional)
- RFA-DK-25-021: Cellular Models of HIV Pathogenesis within NIDDK Mission Areas (R01 Clinical Trial Not Allowed)
- RFA-MD-24-012: Research Centers in Minority Institutions (RCMI) (U54 - Clinical Trial Optional)
- RFA-AG-25-014: Coordinating Center to Support Consortium for Neuroscience Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research in Low- and Middle-Income Countries (LMICs) (U24 Clinical Trial Not Allowed)
- PAR-24-275: Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Mind and Body Interventions (Collaborative UG3/UH3 Clinical Trial Required)
- RFA-DK-26-002: Urology Centers Program Interactions Core (U24 Clinical Trial Not Allowed)
- PA-24-255: Administrative Supplements to Promote Diversity in Research and Development Small Businesses SBIR/STTR (Admin Supp Clinical Trial Not Allowed)
- RFA-DA-25-073: Exploratory Studies to Investigate Mechanisms of HIV infection, Replication, Latency, and/or Pathogenesis in the Context of Substance Use Disorders (R01 Clinical Trial Not Allowed)
- RFA-DE-25-001: Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R01 Clinical Trial Not Allowed)
- RFA-DE-25-002: Organs-on-a-Chip in Dental, Oral, and Craniofacial Research (DOC-OoCs) (R21 Clinical Trial Not Allowed)
- PAR-24-291: Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
- RFA-AG-25-031: Small Research Grant Program for the Next Generation of Researchers in Low- and Middle-Income Countries (LMICs) for Aging and Alzheimers Disease (AD) and AD-Related Dementias (ADRD) Research (R03 Clinical Trial Not Allowed)
- RFA-AG-25-032: Consortium for Neuroscience AD/ADRD in Low- and Middle-Income Countries (U01 Clinical Trial Not Allowed)
- PAR-24-277: Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
- PAR-24-271: NIA Advanced Postdoctoral Career Transition Awards to Promote Diversity in Translational Research for AD/ADRD (K99/R00 Clinical Trial Not Allowed)
- RFA-AT-25-001: HEAL Initiative: Pain Research Enhancement Program (PREP) (R15 Clinical Trial Optional)
- RFA-AI-24-057: Strategies for Eliminating HIV Proteins (R01 Clinical Trial Not Allowed)
- RFA-AI-24-064: Strategies for Eliminating HIV Proteins (R21 Clinical Trial Not Allowed)
- PAR-24-281: NLM Information Resource Grants to Reduce Health Disparities and Promote Health for All (G08 Clinical Trial Not Allowed)
- RFA-AG-25-025: Short Courses Promoting Cross-National Analyses Using Data from the International Health and Retirement Study (HRS) and Harmonized Cognitive Assessment Protocol (HCAP) (R25 Clinical Trial Not Allowed)
- RFA-AG-25-019: The Impact of Stressors on the Biological Mechanisms of Aging and Other Aging-Associated Outcomes in Experimental Model Systems (R61/R33 Clinical Trial Not allowed)
- PAR-24-258: Research Resource for Human Organs and Tissues (U42 Clinical Trial Not Allowed)
- RFA-AG-25-030: Understanding the mechanisms underlying the age-related changes in gait biomechanics and the impact on the increased metabolic cost of walking (R01 Clinical Trial Optional)
- RFA-DA-25-063: Microglial Pathophysiology in Comorbid Substance Use Disorder (SUD) and HIV (R61/R33 Clinical Trial Not Allowed)
- RFA-HG-24-028: Ethical, Legal, and Social Implications (ELSI) Congress (U13, Clinical Trials Not Allowed)
- PAR-24-274: NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
- PAR-24-270: ADRD Risk and Disease Following Nervous System Exposures at Biological Interfaces with the Environment (R01 - Clinical Trial Not Allowed)
- RFA-HD-25-003: Pediatric HIV/AIDS Cohort Study (PHACS) (U19 Clinical Trial Not Allowed)
- PAR-24-262: STTR Solutions to Enable Population Genomic Screening (R41/R42 Clinical Trial Optional)
- PAR-24-263: SBIR Solutions to Enable Population Genomic Screening (R43/R44 Clinical Trial Optional)
- RFA-DK-25-017: Limited Competition for the Continuation of Type 1 Diabetes in Acute Pancreatitis Consortium - Clinical Centers (T1DAPC-CCs) (U01 Clinical Trial Optional)
- RFA-DK-25-018: Single Source for the Continuation of the Type 1 Diabetes in Acute Pancreatitis Consortium - Data Coordinating Center (T1DAPC-DCC) (U01 Clinical Trial Optional)
- RFA-DA-26-007: Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R01 Clinical Trials Not Allowed)
- RFA-DA-26-008: Advancing Research on Molecular Targets and Mechanisms that Influence the Interplay Between Sex Hormones, HIV, and Addictive Substances (R21 Clinical Trials Not Allowed)
- RFA-CA-25-011: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R01 Clinical Trial Optional)
- RFA-CA-25-012: The Confluence of Cancer Stigma and HIV Stigma in HIV-positive Individuals Diagnosed with Cancer (R21 Clinical Trial Optional)
- RFA-DA-26-001: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R01 Clinical Trial Not Allowed)
- RFA-DA-26-002: Single Cell Opioid Responses in the Context of HIV (SCORCH) Program: Data Mining and Functional Validation (R21 Clinical Trial Not Allowed)
- RFA-HG-24-021: Population Genomic Screening in Primary Care Cooperative Agreement (U01 - Clinical Trial Required)
- RFA-HG-24-022: Population Genomic Screening in Primary Care Coordinating Center(U01 -Clinical Trials Optional)
- RFA-HG-24-023: Population Genomic Screening in Primary Care Sequencing Center (U01 - Clinical Trial Optional)
- RFA-CA-24-028: Limited Competition: AIDS Malignancy Consortium (AMC; UM1 Clinical Trial Required)
- RFA-DE-25-004: Collaborative Science to Achieve Disruptive Innovations in Dental, Oral and Craniofacial (DOC) Research (RM1 Clinical Trial Not Allowed)
- RFA-NS-24-037: Optimization of Genome Editing Therapeutics for Alzheimer's Disease-Related Dementias (ADRD) (U01 - Clinical Trials Not Allowed)
- RFA-CA-24-024: Cancer Prevention Clinical Trials Network (CP-CTNet): CP-CTNet Sites (UG1 Clinical Trial Required)
- RFA-CA-24-025: Cancer Prevention Clinical Trials Network (CP-CTNet): Data Management, Auditing, and Statistical Center (DMASC) (UG1 Clinical Trial Required)
- RFA-AG-25-026: Investigating Mitochondrial-Nuclear Communication in AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-DK-25-015: Central Coordinating Site for the Polycystic Kidney Disease Research Core Centers (U24 Clinical Trial Not Allowed)
- RFA-DK-25-016: Polycystic Kidney Disease Core Centers (U54 Clinical Trial Not Allowed)
- RFA-AT-24-011: HEAL Initiative: NIH-DOD-VA Pain Management Collaboratory Pragmatic and/or Implementation Science Demonstration Projects ((UG3/UH3) Clinical Trial Required)
- RFA-DK-25-024: Toward ElucidAting MechanismS of HIV Pathogenesis within the Mission of the NIDDK (Pathogenesis TEAMS) (R01 Clinical Trial Optional)
- PAR-24-267: Functional Validation and/or Characterization of Genes or Variants Implicated in Substance Use Disorders (R21/R33 Clinical Trial Not Allowed)
- PAR-24-259: Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research-Related Operations (S15 Clinical Trial Not Allowed)
- RFA-AI-24-071: Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed)
- RFA-AG-25-029: Short Courses on Utilizing the NIH Stage Model to Develop Behavioral Interventions to Promote Healthy Aging (R25 - Independent Clinical Trial Not Allowed)
- RFA-DK-25-019: The Chronic Pancreatitis Clinical Research Consortium (CPCRC)- Clinical Centers (CPCRC-CCs) (U01 Clinical Trial Optional)
- RFA-DK-25-020: Single Source for Chronic Pancreatitis Clinical Research Consortium (CPCRC) Data Coordinating Center (CPCRC-DCC) (U01 Clinical Trial Optional)
- RFA-AG-25-021: Grants for Early Medical/Surgical Specialists' Transition to Aging Research (GEMSSTAR) (R03 Clinical Trial Optional)
- RFA-AG-25-022: Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD (R01 Clinical Trial Not Allowed)
- RFA-AG-25-023: Deciphering the Impact of RNA Modifications on Brain Aging and AD/ADRD (R21 Clinical Trial Not Allowed)
- RFA-AI-24-041: Novel Approaches for Radiation Biodosimetry and Medical Countermeasure Development (R21 Clinical Trial Not Allowed)
- RFA-DC-24-009: Dissemination and Implementation Research in Communication Disorders Conference (U13 Clinical Trial Not Allowed)
- RFA-CA-24-029: RNA Modifications Driving Oncogenesis (RNAMoDO; U01 Clinical Trial Not Allowed)
- RFA-ES-24-004: Revolutionizing Innovative, Visionary Environmental Health Research (RIVER) (R35 Clinical Trial Optional)
- RFA-TR-24-025: Tissue Chips in Space 2.0: Translational Multi-Organ Tissue Chip Systems for Drug Efficacy, Toxicity Testing, and Personalized Medicine in Human Health, Aging and Associated Diseases (UG3/UH3 Clinical Trial Not Allowed)
- RFA-NS-25-002: Materials to Enhance Training in Experimental Rigor (METER) (UE5 - Clinical Trial Not Allowed)
- PAR-24-224: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Organizational Research Education Award to Promote Diversity (UE5 - Clinical Trial Not Allowed)
- PAR-24-225: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- PAR-24-226: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Clinical Trial Required)
- PAR-24-227: Maximizing Opportunities for Scientific and Academic Independent Careers (MOSAIC) Postdoctoral Career Transition Award to Promote Diversity (K99/R00 - Independent Basic Experimental Studies with Humans Required (BESH))
- RFA-AR-25-005: HEAL Initiative: INTERACT INTEgRAtive Back Pain Longitudinal Cohort Teams (UC2 Clinical Trial Optional)
- RFA-HD-25-005: Women's Reproductive Health Research (WRHR) Career Development Program (K12 Clinical Trial Optional)
- RFA-HD-25-010: The Road to Prevention of Stillbirth Clinical Research Centers (UG1 Clinical Trial Optional)
- RFA-HD-25-011: The Road to Prevention of Stillbirth Data Coordinating Center (UM2 Clinical Trial Not Allowed)
- PAR-24-252: Innovative Programs to Enhance Research Training (IPERT) (R25 Independent Clinical Trial Not Allowed)
- RFA-DA-25-037: Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U01 Clinical Trial Not Allowed)
- RFA-DA-25-038: Translating Socioenvironmental Influences on Neurocognitive Development and Addiction Risk (TranSINDA) (U24 Clinical Trial Not Allowed)
- RFA-AI-24-049: Halting Tuberculosis (TB) Transmission (R01 Clinical Trial Optional)
- PAR-24-232: Bridges to the Doctorate Research Training Program (T32)
- RFA-OD-24-010: Building Sustainable Software Tools for Open Science (R03 Clinical Trial Not Allowed)
- RFA-AR-24-007: HEAL Initiative: HEAL KIDS (Knowledge, Innovation and Discovery Studies): Chronic Pain Program (UC2 Clinical Trial Optional)
- PAR-25-022: NIDCR Mentored Career Development Award to Promote Broad Participation in Research (K01 Independent Clinical Trial Not Allowed)
- PAR-24-256: Archiving and Documenting Child Health and Human Development Data Sets (R03 Clinical Trial Not Allowed)
- PAR-25-023: Device Based Treatments for Substance Use Disorders (UG3/UH3 Clinical Trial Optional)
- RFA-AG-25-020: Claude D. Pepper Older Americans Independence Centers (P30 Clinical Trial Optional)
- RFA-HL-25-007: Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Data Coordinating Center (Collaborative U24 Trial Required)
- RFA-HL-25-010: Phased Multi-Site Clinical Trial: Testing Prevention of Cardiovascular Disease in Young Adults With High Lifetime Risk Using Surrogate Outcomes - Clinical Coordinating Center (Collaborative UG3/UH3 Clinical Trial Required)
- PAR-24-240: Genetic Architecture of Mental Disorders in Ancestrally Varied Populations II (U01 Clinical Trial Not Allowed)
- RFA-HG-24-026: Limited Competition: Building Partnerships and Broadening Perspectives to Advance Ethical, Legal, and Social Implications (ELSI) Research (BBAER) Program (UM1), Clinical Trial Optional
- PAR-24-241: Genetic Architecture of Mental Disorders in Ancestrally Diverse Populations II (U24 Clinical Trial Not Allowed)
- RFA-CA-24-026: National Cancer Institute Youth Enjoy Science Research Education Program (R25 Clinical Trial Not Allowed)
- RFA-MH-26-100: BRAIN Initiative: Brain Behavior Quantification and Synchronization (R61/R33 Clinical Trial Optional)
- RFA-AI-24-045: Promoting Innovative Research in Treponema pallidum Pathogenesis (R21 Clinical Trial Not Allowed)
- RFA-DA-25-085: Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiology and Prevention Intervention Research (U24 Clinical Trials Not Allowed)
- RFA-AG-25-028: Mentored Career Enhancement Awards to Build Cross-Disciplinary Knowledge and Skills for Comparative Studies of Human and Nonhuman Primate Species with Differing Life Spans (K18 Clinical Trial Not Allowed)
- PA-24-247: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)
- PA-24-248: PHS 2024-2 Omnibus Solicitation of the NIH for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Required)
- PA-24-246: PHS 2024-2 Omnibus Solicitation of the NIH and CDC for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Required)
- PA-24-245: PHS 2024-2 Omnibus Solicitation of the NIH, CDC and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)
- PAR-24-250: Standardizing Data and Metadata from Wearable Devices (R01 Clinical Trial Not Allowed)
- RFA-AG-25-011: Early- and Late-Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
- RFA-AG-25-010: Alzheimer's Clinical Trials Consortium (ACTC) Clinical Trials (R01 Clinical Trial Required)
- PAS-24-242: D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
- PAR-24-220: NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Patient-Oriented Research Career Development award (K23 - Clinical Trial Required)
- PAR-24-219: NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Not Allowed)
- PAR-24-218: NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Basic Experimental Studies with Humans (BESH) Required)
- RFA-DA-25-057: Combined Neuromodulation and Behavioral Treatment Algorithm Development for Stimulant Use Disorder (StUD) Enriched for Vulnerable Phenotype (U01 Clinical Trial Required)
- PAR-24-230: B-INSPIRE: Research on Behavioral Interventions that Promote Careers in the Biomedical Research Enterprise (R01 - Clinical Trial Not Allowed)
- PAR-24-243: Advancement and Innovation in Measurement of Language Development and Predictors (R01 Clinical Trial Not Allowed)
- PAR-24-244: Advancement and Innovation in Measurement of Language Development and Predictors (R21 Clinical Trial Not Allowed)
- PAR-24-233: NIMH Research Education Mentoring Program for HIV Researchers (R25 Clinical Trial Not Allowed)
- PAR-24-217: NIH HEAL Initiative PainCare Clinician Training Program (PCTP): Mentored Clinical Scientist Development Awards (K08 - Clinical Trials Required)
- RFA-MH-25-195: Individually Measured Phenotypes to Advance Computational Translation in Mental Health (IMPACT-MH) (U01 Clinical Trial Optional)
- RFA-NS-24-035: Novel Preclinical Models of NeuroHIV in the cART Era (R61/R33 - Clinical Trial Not Allowed)
- PAR-24-223: Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
- PAR-24-249: Interaction Between Environmental Factors and Lewy Body Dementia (R01 - Clinical Trial Not Allowed)
- PAR-24-228: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Not Allowed)
- PAR-24-229: NINDS Faculty Development Award to Promote Diversity in Neuroscience Research (K01 Independent Clinical Trial Required)
- RFA-NS-24-040: The NINDS Human Cell and Data Repository (U24 - Clinical Trial Not Allowed)
- PAR-24-212: NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award to Promote Diversity (K99/R00 Independent Clinical Trial Not Allowed)
- PAR-24-213: NINDS Alzheimers Disease-Related Dementias (ADRD) Advanced Postdoctoral Career Transition Award (K99/R00 Independent Clinical Trial Not Allowed)
- PAR-24-222: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Pre-Clinical Research (R44 Clinical Trial Not Allowed)
- RFA-DA-25-044: Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Basic Experimental Studies with Humans Required)
- RFA-DA-25-045: Mechanistic Studies to Investigate the Interrelationship Between Sleep and/or Circadian Rhythms and Substance Use Disorders (R01 Clinical Trials Not Allowed)
- PAR-24-030: CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed)
- PAR-24-221: NINDS Renewal Awards of SBIR Phase II Grants (Phase IIB) for Clinical Trials and Clinical Research (R44 Clinical Trial Optional)
- RFA-AI-24-029: Mechanisms of Inducing HIV Immunity in Early Life (MIEL) (U01 Clinical Trial Not Allowed)
- RFA-AT-24-010: Whole Person Research and Coordination Center (Whole Person RCC) U24 (Clinical Trial Not Allowed)
- PAR-24-238: Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional)
- PAR-24-239: Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional)
- RFA-MD-24-009: Limited Competition: NIMHD Initiative for Improving American Indian and Alaska Native Cancer Outcomes (U19 - Clinical Trial Optional)
- PAR-24-204: Summer Research Education Experience Program (R25 Clinical Trial Not Allowed)
- RFA-MH-25-180: Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R01 Clinical Trial Not Allowed)
- RFA-MH-25-181: Mechanisms of Reciprocal Interactions between HIV Associated Neuroinflammation and CNS Persistence: Implications in HIV Neuropathogenesis and Cure (R21 Clinical Trial Not Allowed)
- RFA-DA-25-049: Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R41/R42 - Clinical Trial Optional)
- RFA-DA-25-050: Solutions to enable diagnosis and treatment of adverse health consequences of non-disordered drug use (R43/R44 - Clinical Trial Optional)
- RFA-MH-25-135: Research Opportunities in Crisis Response Services for Suicide Prevention (R01 Clinical Trial Optional)
- RFA-MH-25-136: Pilot Research Opportunities in Crisis Response Services for Suicide Prevention (R34 Clinical Trial Optional)
- RFA-AG-25-003: Research Collaboration Network in Structural Racism Measurement and Modeling (U24 Clinical Trial Optional)
- PAR-24-231: Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
- RFA-DA-25-040: Translational Resource Centers to Build Bridges Between Substance Use Epidemiology/Etiology and Prevention Intervention Research (U24 Clinical Trials Not Allowed)
- RFA-NS-25-013: Clinical Trial Readiness to Understand and Develop Solutions to Social, Ethical, Behavioral Implications and Barriers to Health Equity in ADRD (R01 - Clinical Trial Not Allowed)
- RFA-CA-24-027: Addressing Barriers to Healthcare Transitions for Survivors of Childhood and Adolescent Cancers (R01 Clinical Trial Optional)
- RFA-ES-24-005: CCRP Initiative: Chemical Threat Agent-induced Pulmonary and Ocular Pathophysiological Mechanisms (R01 Clinical Trial Not Allowed)
- RFA-HD-25-002: Centers for Collaborative Research in Fragile X and FMR1-Associated Conditions (P50 Clinical Trial Optional)
- RFA-DA-25-025: HEAL Initiative: JCOIN Phase II Clinical Research Hubs (UM1 Clinical Trial Required)
- RFA-DA-25-026: HEAL Initiative: JCOIN Phase II Community Engaged Research Resource Center (U24 Clinical Trial Optional)
- RFA-DA-25-061: HEAL Initiative: JCOIN Phase II Economic Research Resource Center (U24 Clinical Trial Optional)
- RFA-DA-25-062: HEAL Initiative: JCOIN Phase II Innovation Hubs (R01 Clinical Trial Optional)
- PAR-24-199: T32 Training Program for Institutions That Promote Diversity (T32 Clinical Trial Not Allowed)
- PAR-24-234: Mechanistic Investigations into ADRD Associated Protein Structures in Biological Settings (R01 - Clinical Trial Not Allowed)
- RFA-DK-25-012: Single Source for the Continuation of the Human Pancreas Analysis Program (HPAP) for Type 1 Diabetes (HPAP-T1D) (U01 Clinical Trial Not Allowed)
- RFA-MH-25-160: Suicide Prevention Across the Life Span in Low- and Middle-Income Countries (R34 Clinical Trial Optional)
- RFA-AT-24-009: REsearch Across Complementary and Integrative Health Institutions (REACH) Virtual Resource Centers (U24 Clinical Trial Not Allowed)
- RFA-NS-25-011: Functional Target Validation for Alzheimer's Disease-Related Dementias (R61/R33 Clinical Trial Not Allowed)
- RFA-DA-25-056: Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trials Not Allowed)
- RFA-DC-24-008: Early-Stage Dissemination and Implementation Research in Communication Disorders (R21 Clinical Trial Optional)
- RFA-DA-24-040: BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trial Optional)
- RFA-DA-24-041: BRAIN Initiative: Brain-Behavior Quantification and Synchronization Transformative and Integrative Models of Behavior at the Organismal Level (U01 Clinical Trials Not Allowed)
- RFA-NS-24-041: NIH HEAL Initiative: Coordinated Approaches to Pain Care in Health Care Systems (UG3/UH3 - Clinical Trial Optional)
- PAR-24-208: NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- PAR-24-215: Single Source: NINDS Exploratory Clinical Trials (U01 Clinical Trial Required)
- PAR-25-021: NIDCR Dual Degree Dentist Scientist Predoctoral to Postdoctoral Transition Award (F99/K00 Independent Clinical Trial Not Allowed)
- RFA-ES-24-003: SBIR E-Learning for HAZMAT and Emergency Response (R43/R44 Clinical Trial Not Allowed)
- RFA-NS-25-010: Safety and Efficacy of Amyloid-Beta Directed Antibody Therapy in Mild Cognitive Impairment and Dementia with Evidence of Lewy Body Dementia and Amyloid-Beta Pathology (U01 - Clinical Trial Required)
- RFA-ES-24-002: HAZMAT Training at DOE Nuclear Weapons Complex (UH4 Clinical Trial Not Allowed)
- RFA-AG-25-024: Access and Manipulation of Brain Cell Subtypes Implicated in Aging and AD/ADRD (R61/R33 Clinical Trial Not allowed)
- RFA-EY-24-003: NEI Research for Low Vision and Blindness Accessibility Tools (R61/R33 Clinical Trial Optional)
- RFA-DK-25-011: Nutrition Obesity Research Centers Research Resource Center (RRC) (P2C- Clinical Trial Optional)
- RFA-DK-25-007: Nutrition Obesity Research Centers (P30 Clinical Trial Optional)
- PAR-24-200: NINDS Research Education Opportunities (R25 Clinical Trial Not Allowed)
- PAR-24-207: Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
- RFA-HG-24-004: ML/AI Tools to Advance Genomic Translational Research (MAGen) - Development Sites (UG3/UH3 Clinical Trials Not Allowed)
- RFA-HG-24-005: ML/AI Tools to Advance Genomic Translational Research (MAGen) - Coordinating Center (UG3/UH3, Clinical Trials Not Allowed)
- RFA-AR-25-002: Senator Paul D. Wellstone Muscular Dystrophy Specialized Research Centers (MDSRC) (P50 Clinical Trial Optional)
- RFA-HL-25-008: Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Required)
- RFA-HL-25-009: Mentored Career Development Award to Promote Faculty Diversity in Biomedical Research (K01 Independent Clinical Trial Not Allowed)
- PAR-24-152: Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- RFA-AA-24-007: Specialized Alcohol Research Centers (P50 Clinical trial Optional)
- RFA-AA-24-008: Comprehensive Alcohol Research Centers (P60 Clinical trial Optional)
- RFA-ES-24-001: Hazardous Materials Worker Health and Safety Training (U45 Clinical Trials Not Allowed)
- PAR-24-202: Lasker Clinical Research Scholars Program (Si2/R00 Clinical Trial Optional)
- RFA-MH-25-185: Advancing HIV service delivery through pharmacies and pharmacists (R01 Clinical Trial Optional)
- RFA-MH-25-186: Advancing HIV service delivery through pharmacies and pharmacists (R21 Clinical Trial Optional)
- RFA-DK-25-005: Type 1 Diabetes TrialNet Clinical Network Hub (U01 Clinical Trial Not Allowed)
- PA-24-180: Independent Scientist Award (Parent K02 Independent Basic Experimental Studies with Humans Required)
- PAR-24-132: Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Required)
- RFA-DK-25-004: Coordinating Center for Type 1 Diabetes TrialNet (U01 Clinical Trial Required)
- RFA-NR-24-006: Understanding the Intersection of Social Inequities to Optimize Health and Reduce Health Disparities: The Axes Initiative (R01 Clinical Trial Optional)
- PAR-24-131: Small Business Transition Grant for New Entrepreneurs (R43/R44 Clinical Trial Not Allowed)
- PA-24-189: Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Independent Basic Experimental Studies with Humans Required)
- RFA-AI-24-025: Engineering Durable HIV Vaccine Responses (ENDURE) (R01 Clinical Trial Not Allowed)
- PAR-24-133: Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Not Allowed)
- PAR-24-134: Small Business Transition Grant for New Entrepreneurs (R41/R42 Clinical Trial Required)
- PA-24-183: Mentored Clinical Scientist Research Career Development Award (Parent K08 Independent Basic Experimental Studies with Humans Required)
- PA-24-177: Mentored Research Scientist Development Award (Parent K01 Independent Basic Experimental Studies with Humans Required)
- RFA-AG-25-004: Safety and Early Efficacy Studies of Psychedelic-Assisted Therapy for Chronic Pain in Older Adults (UG3/UH3 Clinical Trial Required)
- PA-24-195: NIH Pathway to Independence Award (Parent K99/R00 Independent Basic Experimental Studies with Humans Required)
- RFA-HD-25-009: Using Archived Data and Specimen Collections to Advance Maternal and Pediatric HIV/AIDS Research (R21 - Clinical Trial Not Allowed)
- RFA-DK-25-010: Cystic Fibrosis Research and Translation Centers (P30 Clinical Trial Optional)
- RFA-AI-24-017: Human Leukocyte Antigen (HLA) and Killer-cell Immunoglobulin-like Receptor (KIR) Region Genomics in Immune-Mediated Diseases (U01 Clinical Trial Not Allowed)
- PA-24-192: Mentored Quantitative Research Development Award (Parent K25 Independent Basic Experimental Studies with Humans Required)
- RFA-CA-24-022: SBIR Phase IIB Bridge Awards to Accelerate the Development of Cancer-Relevant Technologies Toward Commercialization (R44 Clinical Trial Optional)
- RFA-CA-24-023: Small Business Transition Grant For Early Career Scientists (R41/R42 Clinical Trial Not Allowed)
- PAR-24-110: Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- PAR-24-174: Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)
- PAR-24-197: HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
- RFA-MH-25-130: Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
- PAR-24-166: Promoting Broad Participation in NIDCD's Extramural Workforce through Research Education Experiences and/or Mentoring Networks (R25 - Independent Clinical Trial Not Allowed)
- RFA-DA-25-035: Using Neuromodulation to Characterize the Continuum of Pathophysiology Between Substance Use and Mental Health Disorders (R01 Clinical Trial Required)
- PAR-24-139: NIDCR Predoctoral to Postdoctoral Transition Award to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (F99/K00 Independent Clinical Trial Not Allowed)
- PAR-24-203: Neuropathological Interactions Between COVID-19 and ADRD (R01 - Clinical Trial Not Allowed)
- PAR-24-198: Protective Strategies to Reduce Amyloid Related Imaging Abnormalities (ARIA) After Anti-Amyloid Beta Immunotherapy (R01 - Clinical Trial Not Allowed)
- PAR-24-168: Feasibility Trials of the NIH Music-based Interventions Toolkit for Brain Disorders of Aging (R34 Clinical Trial Required)
- PA-24-186: Mentored Patient-Oriented Research Career Development Award (Parent K23 Independent Basic Experimental Studies with Humans Required)
- RFA-DA-25-039: Education Activities for Responsible Analyses of Complex, Large-Scale Data (R25- Clinical Trial Not Allowed)
- RFA-AI-24-013: Cell and Gene Therapies for HIV Cure: Developing a Pipeline (P01 Clinical Trial Not Allowed)
- RFA-TR-24-021: Single Source for the Continuation of the Data Management and Coordinating Center (DMCC) for Rare Diseases Clinical Research Network (RDCRN) (U2C Clinical Trial Not Allowed)
- PAR-24-196: Mechanistic and Hemodynamic Basis of Diffuse White Matter Disease in Vascular Contributions to Cognitive Impairment and Dementia (VCID)(R01 - Clinical Trial Not Allowed)
- RFA-RM-24-006: Pilot Projects Enhancing Utility and Usage of Common Fund Data Sets (R03 Clinical Trial Not Allowed)
- RFA-DK-25-009: Kidney Technology Development Research Education Program (R25 - Independent Clinical Trial Not Allowed)
- RFA-TR-24-023: Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- RFA-HD-25-001: Medical Rehabilitation Research Resource (P50 Clinical Trial Optional)
- RFA-MH-25-190: Precision Mental Health: Develop Tools to Inform Treatment Selection in Depression (UG3/UH3 Clinical Trial Optional)
- PAR-24-206: Rare Diseases Clinical Research Consortia (RDCRC) for the Rare Diseases Clinical Research Network (RDCRN) (U54 Clinical Trial Optional)
- PAR-24-173: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- RFA-DK-23-007: Discovery of Early Type 1 Diabetes Disease Processes in the Human Pancreas [HIRN Consortium on Beta Cell Death and Survival (CBDS)] (U01 Clinical Trial Not Allowed)
- RFA-AI-24-019: Immunobiology of Xenotransplantation (U01 Clinical Trial Not Allowed)
- RFA-AI-24-020: Immunobiology of Xenotransplantation (U19 Clinical Trial Not Allowed)
- RFA-AI-24-021: Partnerships for the Development of Tools to Advance Therapeutic Discovery for Select Antibiotic-Resistant Gram-Negative Bacteria (R01 Clinical Trial Not Allowed)
- RFA-DK-24-002: Adaptation of Diabetes Control Technologies for Older Adults with T1D (R01 Clinical Trial Optional)
- PAR-24-172: NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- RFA-DK-25-008: Diabetes Research Centers (P30 Clinical Trial Optional)
- RFA-HL-26-001: Limited Competition: Physician Scientist Transition to Independence in Blood Science Research (R00 - Clinical Trial Optional)
- RFA-NS-24-034: Tools and resources to understand the vascular pathophysiology of in vivo neuroimaging findings in ARIA (U24 - Clinical Trials Not Allowed)
- RFA-AI-24-009: Limited Interaction Targeted Epidemiology: Epidemiology of Transmission and Treatment of HIV Among People Who Are at Increased Risk for HIV Infection in Latin America (LITE-LA) (UG3/UH3 Clinical Trial Optional)
- RFA-AI-24-018: Interaction between ARVs and Hormones in HIV and Coinfections (R01 Clinical Trial Optional)
- PAR-24-137: Undergraduate Research Training Initiative for Student Enhancement (U-RISE) (T34)
- PAR-24-138: Maximizing Access to Research Careers (MARC) (T34)
- PAR-24-169: NINDS Program Project Grant (P01 Clinical Trial Optional)
- RFA-AI-24-006: Centers for Research in Emerging Infectious Diseases (CREID) Network (U01 Clinical Trial Not Allowed)
- RFA-AI-24-016: Centers for Research in Emerging Infectious Diseases (CREID) Network Coordination Center (U01 Clinical Trial Not Allowed)
- RFA-CA-24-020: Specialized Programs of Research Excellence (SPOREs) in Cancer Health Disparities and Minority Health (CHD-MH) (U54 Clinical Trial Optional)
- RFA-AI-24-010: Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND for TB) (R01 Clinical Trial Not Allowed)
- RFA-AI-24-008: Strategies for Controlled Release of HIV Vaccines (SCORE-H) (R01 Clinical Trial Not Allowed)
- RFA-NS-25-012: HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
- PAR-24-164: Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- PAR-24-165: AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- RFA-RM-24-007: Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allowed)
- RFA-AI-24-011: Tailoring HIV Curative Strategies to the Participant (UM1 Clinical Trial Not Allowed)
- RFA-RM-24-002: NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)
- RFA-NS-24-016: BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional)
- RFA-HD-25-004: Optimizing Health of Children and Adolescents with Perinatal HIV Exposure (U19 Clinical Trial Optional)
- RFA-RM-24-003: NIH Directors New Innovator Award Program (DP2 Clinical Trial Optional)
- PAR-24-160: New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- PAR-24-161: New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- RFA-NS-24-017: BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional)
- RFA-RM-24-005: NIH Directors Early Independence Awards (DP5 Clinical Trial Optional)
- RFA-MH-25-110: BRAIN Initiative: Data Archives for the BRAIN Initiative (R24 Clinical Trial Optional)
- RFA-MH-25-120: Lethal Means Safety Suicide Prevention Research in Healthcare and Community Settings (R34 Clinical Trial Required)
- RFA-AG-25-012: Nathan Shock Centers of Excellence in Basic Biology of Aging (P30 Clinical Trial Not Allowed)
- RFA-AG-25-013: Nathan Shock Centers Coordinating Center (U24 Clinical Trial Not Allowed)
- RFA-NS-25-014: Mechanisms of Cognitive Fluctuations in ADRD Populations (R01 - Clinical Trial Optional)
- RFA-RM-24-004: NIH Directors Transformative Research Awards (R01 Clinical Trial Optional)
- PAR-24-162: Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
- RFA-DA-25-004: Research on the Neuro-Immune Axis in the context of HIV and Substance Use (R01 Clinical Trial Not Allowed)
- RFA-DA-25-005: Research on the Neuro-Immune Axis in the Context of HIV and Substance Use (R21 Clinical Trial Not Allowed)
- RFA-AT-24-007: Limited Competition: Research Resource for Natural Product Nuclear Magnetic Resonance Data (R24 Clinical Trial Not Allowed)
- PAR-24-144: Support for Research Excellence (SuRE) Award (R16 Clinical Trial Not Allowed)
- PAR-24-145: Support for Research Excellence First Independent Research (SuRE-First) Award (R16 - Clinical Trial Not Allowed)
- RFA-OD-24-014: Botanical Dietary Supplements Translational Research Teams (RM1 Clinical Trial Required)
- RFA-AG-25-017: Exploring Proteogenomic Approaches to Unravel the Mechanisms of Mis-Folded Protein Accumulation in Tauopathies (R01 Clinical Trial Not Allowed)
- PAR-24-121: Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
- PAR-24-167: Utilizing Equipment to Study Environmental Extrinsic Factors and Enhance Rigor and Reproducibility of Animal Research (R24, Clinical Trials Not-Allowed)
- PAR-24-126: NINDS Advanced Institutional Research Training Program (T32 Clinical Trial Not Allowed)
- PAR-24-104: NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workforce (UE5 Clinical Trial Not Allowed)
- RFA-AI-23-077: Center of Excellence for Systems Modeling of Infection and Immunity across Biological Scales (U54 Clinical Trial Not Allowed)
- RFA-MD-24-006: Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparities (R43/R44 - Clinical Trial Optional)
- RFA-MD-24-007: Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Clinical Trial Optional)
- RFA-AA-24-004: Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment Clinical Trials Clinical Centers (U01-Clinical Trial required)
- PA-24-141: NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)
- RFA-NR-24-005: Strategies to Improve Health Outcomes and Advance Health Equity in Rural Populations (R01 Clinical Trial Optional)
- RFA-AA-24-006: Model Continuums of Care Initiative (MCCI) to Advance Health Equity and End Health Disparities Among Women and Girls in Racial/Ethnic Minority and Other Underserved Communities (U34 Clinical Trials Required)
- RFA-AA-24-005: Limited Competition: Alcohol-associated Hepatitis Clinical Network Integrated Treatment Clinical Trials Data Coordinating Center (U24 - Clinical Trial Required)
- RFA-AT-24-008: Leveraging Data at Scale to Understand Natural Product Impacts on Whole Person Health (R01 Clinical Trial Not Allowed)
- RFA-MD-24-005: Elucidating Mechanisms Associated with HIV Related Co-Morbidities in Populations Experiencing Health Disparities (R01 - Clinical Trials Not Allowed)
- RFA-DK-25-013: Impact of Comorbidities and Co-Infections on HIV Reservoirs (R01 Clinical Trial Not Allowed)
- RFA-OD-24-012: Predoctoral Training in Advanced Data Analytics for Behavioral and Social Sciences Research (BSSR) - Institutional Research Training Program [T32]
- PAS-24-163: Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
- PAR-24-108: Institutional Translational Research Training Program (T32 - Clinical Trial Not Allowed)
- PAR-24-157: Addressing Health Inequities in Clinical Diagnostics (R41/R42 Clinical Trials Not Allowed)
- PAR-24-158: Addressing Health Inequities in Clinical Diagnostics (R43/R44 Clinical Trials Not Allowed)
- RFA-AG-25-009: Research Training in Aging for Medical Students (T35)
- PAR-24-119: NIDCD Early Career Research(ECR) Award (R21 Clinical Trial Optional)
- PAR-24-064: Developing Digital Therapeutics for Substance Use Disorders (UG3/UH3 Clinical Trial optional)
- PAR-24-150: NIDCD Mentored Career Development Award for Postdoctorate Au.D./Ph.D. Audiologists (K01 Independent Basic Experimental Studies with Humans Required)
- RFA-OD-24-013: Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial Optional)
- PAR-24-151: Translational Neural Devices (R61/R33 - Clinical Trial Optional)
- PAR-24-135: NIA MSTEM: Advancing Diversity in Aging Research (ADAR) through Undergraduate Education (R25 - Independent Clinical Trial Not Allowed)
- RFA-OD-24-007: INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndromE) Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 Clinical Trial Not Allowed)
- RFA-AG-25-002: Consortium for Palliative Care Research Across the Lifespan (U54 Clinical Trial Optional)
- PAR-24-109: Long-Term Effects of Disasters on Healthcare Systems in Populations with Health Disparities (R01- Clinical Trial Optional)
- RFA-MH-25-105: BRAIN Initiative: Production and distribution facilities for brain cell type-specific access reagents (U24 Clinical Trial Not Allowed)
- RFA-MH-25-100: BRAIN Initiative: Scaled reagent resources for brain cell type-specific access across vertebrate species (U01 Clinical Trial Not Allowed)
- RFA-DA-25-043: Transformative Research on the Basic Mechanisms of Polysubstance use in Addiction (R01 - Clinical Trials Optional)
- RFA-NS-24-032: Development and Validation of Human Cellular Models for Alzheimer's Disease-Related Dementias (ADRD) (R01 - Clinical Trial Not Allowed)
- RFA-MH-25-170: BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R01 Clinical Trial Optional)
- RFA-MH-25-171: BRAIN Initiative: Research on the Ethical Implications of Advancements in Neurotechnology and Brain Science (R21 Clinical Trial Optional)
- RFA-AA-24-003: Limited Competition: Collaborative Study on the Genetics of Alcoholism (COGA) (U10 Clinical Trial Not Allowed)
- PAR-24-079: NINDS Research Education Programs for Residents and Fellows in Neurological Disorders and Stroke (UE5 - Clinical Trial Not Allowed)
- PAR-24-120: NIA Career Transition Award (K22 Independent Clinical Trial Not Allowed)
- RFA-AG-25-005: Open Measurement Coordinating Network for Non-Pharmacological Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) Primary Prevention Trials (U24 Clinical Trail Not Allowed)
- PAR-24-127: NIDCD's Mentored Research Education Pathway for Otolaryngology Residents and Medical Students (R25 - Clinical Trial Not Allowed)
- PAR-24-117: The NCI Transition Career Development Award (K22 Independent Clinical Trial Optional)
- PAR-24-118: Advancing Learning Health Care Research in Outpatient Mental Health Treatment Settings (R34 Clinical Trial Optional)
- PAR-24-142: NIDCD Research Career Enhancement Award for Established Investigators (K18 Independent Basic Experimental Studies with Humans Required)
- RFA-AG-25-016: Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)
- PAR-24-147: Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed)
- PAR-24-148: Investigating Distinct and Overlapping Mechanisms in TDP-43 Proteinopathies, including in LATE, FTD and other ADRDs (R01 - Clinical Trial Not Allowed)
- PAR-24-125: Natural Product Multi-Site Clinical Trial Data Coordinating Center (Collaborative U24 Clinical Trial Required)
- RFA-NS-24-030: NIH Blueprint and BRAIN Initiative Diversity Specialized Predoctoral to Postdoctoral Advancement in Neuroscience (D-SPAN) Award (F99/K00 Clinical Trial Not Allowed)
- PAR-24-123: Clinical Coordinating Center for NCCIH Multi-Site Investigator-Initiated Clinical Trials of Natural Products (Collaborative UG3/UH3 Clinical Trial Required)
- PAR-24-116: NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- PAR-24-124: NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
- RFA-DK-23-011: Continuous Ketone Monitoring for the Safe Use of Sodium-glucose Cotransporter-2 Inhibitors in Type 1 Diabetes (R01 Clinical trial Required)
- RFA-DA-25-053: Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R41/R42 Clinical Trials Not Allowed)
- RFA-DA-25-054: Harnessing Artificial Intelligence and Polypharmacology to Discover Pharmacotherapeutics for Substance Use Disorders (R43/R44 Clinical Trials Not Allowed)
- RFA-DA-25-032: Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trial Optional)
- RFA-DA-25-034: Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Clinical Trials Not Allowed)
- PAR-24-099: NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)
- RFA-DA-25-033: Mechanistic Studies on Social Behavior in Substance Use Disorder (R01 Basic Experimental Studies with Humans (BESH) Required)
- PAR-24-100: NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)
- PAR-24-111: Understanding Mechanisms and Outcomes of Trained Immunity (R21 Clinical Trial Not Allowed)
- RFA-AI-24-003: Novel Approaches for Radiation Biodosimetry Assays and Devices Development (U01 Clinical Trial Not Allowed)
- PAR-24-112: Understanding Mechanisms and Outcomes of Trained Immunity (R01 Clinical Trial Not Allowed)
- RFA-NR-24-004: Transformative Research to Address Health Disparities and Advance Health Equity (U01 Clinical Trial Optional)
- PAR-24-095: Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders(U01 Clinical Trial Optional)
- PAR-24-096: Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
- PAR-24-098: Analytical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
- PAR-24-097: Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U01 Clinical Trial Optional)
- PAR-24-113: International Research Scientist Development Award (IRSDA) (K01) Independent Clinical Trial Not Allowed
- PAR-24-129: Limited Competition: Specific Pathogen Free Macaque Colonies to Support HIV/AIDS Research (U42 Clinical Trial Not Allowed)
- RFA-OD-24-008: Clinical Sites for the Environmental influences on Child Health Outcomes (ECHO) IDeA States Pediatric Clinical Trials Network - 3 (UG1 Clinical Trial Required)
- RFA-OD-24-009: Data Coordinating and Operations Center for the ECHO IDeA States Pediatric Clinical Trials Network - 3 (U24 Clinical Trial RequiredInfrastructure)
- PAR-24-114: International Research Scientist Development Award (IRSDA) (K01 Independent Clinical Trial Required)
- PAR-24-122: Modular R01s in Cancer Control and Population Sciences (R01 Clinical Trial Optional)
- RFA-HG-24-013: NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)
- PAR-24-078: Limited Competition: Specific Pathogen Free Macaque Colonies (U42 Clinical Trial Not Allowed)
- PAR-24-107: Solutions to Enable Regional Genomic Medicine eConsult Services (R41/R42 Clinical Trial Optional)
- PAR-24-106: Solutions to Enable Regional Genomic Medicine eConsult Services (R43/R44 Clinical Trial Optional)
- RFA-HG-24-001: Research on the Impact of and Methods for Implementing Regional Genomic Medicine eConsult Services (U01 Clinical Trials Optional)
- PAR-24-060: Pilot and Feasibility Studies in Preparation for Substance Use Prevention Trials (R34 Clinical Trial Optional)
- PAR-24-094: NIDDK High Risk Multi-Center Clinical Study Implementation Planning Cooperative Agreements (U34 Clinical Trial Optional)
- PAR-24-102: NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Not Allowed)
- PAR-24-103: NIDDK High Risk Multi-Center Clinical Study Cooperative Agreement (U01 Clinical Trial Required)
- PAR-24-105: Limited Competition: Mutant Mouse Resource and Research Centers (U42 Clinical Trial Not Allowed)
- RFA-HG-24-006: NHGRI Technology Development Coordinating Center (U24 Clinical Trial Not Allowed)